Tag: #remdesivir
-
PHA rebukes accusations of alleged Remdesivir ‘overpricing’
The Philippine Hospital Association (PHA) said that it is not right to accuse various hospitals in the country of overpricing antiviral drug Remdesivir that is being used for the treatment of coronavirus disease (COVID-19) patients.
-
Doctor appeals for help as fake receipts for Remdesivir being sold under his name surface
A pediatric neurosurgeon asked for help on social media after he found out that a coronavirus disease (COVID-19) drug was being sold using receipts under his name.
-
DOH, DTI investigate complaints on overpricing of Remdesivir
The Department of Health (DOH) warned the public against overpricing Remdesivir, an investigational drug used in treating coronavirus disease (COVID-19) patients.
-
DOST: WHO conducts further studies on use of Remdesivir vs COVID-19
The World Health Organization (WHO) is further conducting studies on the use of antiviral drug Remdesivir against coronavirus disease (COVID-19), the Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) said on Thursday, May 20.
-
We don't have procurement of Remdesivir, says Health official
The Department of Health (DOH) said it is not procuring the antiviral drug Remdesivir being used by coronavirus disease (COVID-19) patients.
-
Gov't prepares to procure more oxygen, Remdesivir supplies for COVID-19 patients
The government has firmed up contingency plans to secure more medical oxygen supplies as well as Remdevisir to help with the treatment of coronavirus patients in the country.
-
FDA: Remdesivir has no product registration in PH
The Food and Drug Administration (FDA) on Monday, May 3, clarified that Remdesivir, an investigational drug currently being used in the country on patients with coronavirus disease (COVID-19), has no Certificate of Product Registration (CPR) in the Philippines.
-
DOH: PH looks for other suppliers of investigational drugs vs. COVID-19
The Philippines is now looking at other suppliers of investigational drugs against the coronavirus disease (COVID-19) as India, a major drug supplier worldwide, is now battling a surge in infections.
-
Pro-science consumer group president asks crucial question to Ivermectin backers
Science-savvy consumer advocacy group Alyansa ng mga Grupong Haligi ng Agham at Teknolohiya Para sa Mamamayan (AGHAM) underscored on Sunday, April 25 a key difference between Ivermectin and Remdesivir, two popular drugs being repurposed for the treatment of the dreaded coronavirus disease (COVID-19).
-
DOH warns public on overpricing of Remdesivir
The Department of Health (DOH) on Friday, April 23 warned the public on the overpricing of Remdesivir.